Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Sales of Property, Plant and Equipment (2012)

Updated

Emmaus Life Sciences' Sales of Property, Plant and Equipment came in at $4,000 for FY2024.

Analysis

Emmaus Life Sciences (EMMA) Sales of Property, Plant and Equipment (2012) Analysis & Trends

  • The FY2024 figure represents the lowest annual Sales of Property, Plant and Equipment since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -4.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 26.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 1,400.00
API Access

Emmaus Life Sciences Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EMMA&period=max&api_key=YOUR_API_KEY